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Background: Equine recurrent laryngeal neuropathy (RLN) is a bilateral mononeuropathy with an unknown
pathogenesis that significantly affects performance in Thoroughbreds. A genetic contribution to the pathogenesis
of RLN is suggested by the higher prevalence of the condition in offspring of RLN-affected than unaffected stallions.
To better understand RLN pathogenesis and its genetic basis, we performed a genome-wide association (GWAS) of
282 RLN-affected and 268 control Thoroughbreds.
Results: We found a significant association of RLN with the LCORL/NCAPG locus on ECA3 previously shown to affect
body size in horses. Using height at the withers of 505 of these horses, we confirmed the strong association of this
locus with body size, and demonstrated a significant phenotypic and genetic correlation between height and RLN
grade in this cohort. Secondary genetic associations for RLN on ECA18 and X did not correlate with withers height
in our cohort, but did contain candidate genes likely influencing muscle physiology and growth: myostatin (MSTN)
and integral membrane protein 2A (ITM2A).
Conclusions: This linkage between body size and RLN suggests that selective breeding to reduce RLN prevalence
would likely reduce adult size in this population. However, our results do not preclude the possibility of modifier
loci that attenuate RLN risk without reducing size or performance, or that the RLN risk allele is distinct but tightly
linked to the body size locus on ECA3. This study is both the largest body size GWAS and the largest RLN GWAS
within Thoroughbred horses to date, and suggests that improved understanding of the relationship between
genetics, equine growth rate, and RLN prevalence may significantly advance our understanding and management
of this disease.
Keywords: Recurrent laryngeal neuropathy (RLN), Thoroughbred, Horse, Equus caballus, Genome-wide association
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Equine recurrent laryngeal neuropathy (also known
as idiopathic laryngeal hemiplegia) is a common upper
respiratory tract disorder of horses and a significant
cause of their reduced athletic performance [1]. RLN
represents a distal axonopathy of the recurrent laryngeal
nerves, which is clinically expressed only on the left side
of the larynx. Interestingly, the left nerve is the longest* Correspondence: robinson@cvm.msu.edu
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unless otherwise stated.nerve in horses [2,3]. RLN is also a mononeuropathy, as
other peripheral nerves of the horse remain unaffected
[4]. As a result of the axonal degeneration, secondary
paresis to complete paralysis of the intrinsic laryngeal
abductor and adductor muscles ensues. Although RLN
results in fiber-type grouping in all of the intrinsic laryngeal
muscles, it is neurogenic atrophy of one particular ab-
ductor, theMusculus cricoarytenoideus dorsalis (CAD), that
prevents maximal abduction of the arytenoid cartilage and
contributes to the development of airway obstruction. The
degree of CAD paresis/paralysis is graded endoscopically
from 1 to 4 [5] and a significant correlation between thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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CAD has been documented [6].
Recurrent laryngeal neuropathy is an important axo-
nopathy for horses in competitive events, because the re-
sultant paresis of the intrinsic laryngeal muscles leads to
obstruction of air flow during intense exercise, an abnor-
mal inspiratory noise known as “roaring,” and, most im-
portantly, reduced performance. Despite its importance,
however, the etiology of the axonopathy is unknown.
RLN has particular economic importance in Thorough-
bred racehorses because these animals enter race train-
ing as 2-year-olds. Even though all horses going through
sales are endoscopically examined for evidence of RLN,
the condition may not yet be clinically evident in some
animals [7] so a diagnostic test to predict RLN risk
would be very useful.
The prevalence of RLN varies, ranging from between
2-11% in Thoroughbreds [8,9] and 35-46% in the Draft
horse breeds [10,11]. In draft breeds, taller horses are at
greater risk of developing RLN, but the relationship be-
tween height and RLN in Thoroughbreds has not been
clearly defined [11,12]. From a genetic point of view, all
modern Thoroughbreds originated from three stallions
imported into England in the 17th and 18th century that
were crossbred to local mares [13]. As a consequence of
this restricted founder stock and strong selection for
racing performance, modern Thoroughbreds exhibit
low genetic diversity and high linkage disequilibrium
[14], making them particularly well suited to identify
genetic associations using a genome-wide association
study (GWAS) approach.
The presence of genetic factors contributing to the
pathogenesis of RLN is suggested by the observation that
offspring of RLN-affected stallions are more likely to be
affected with the disorder than are offspring from un-
affected stallions [15,16]. Elucidating the genetic mechan-
ism causing the disease is of particular research interest
since, unlike most myelinopathies, RLN manifests itself as
a bilateral mononeuropathy [4,17]. However, the genetics
of RLN have not been extensively investigated. A GWAS of
RLN has been conducted [17] in a mixed population of
horses consisting of 234 cases (196 Warmbloods, 20 Trot-
ters, 14 Thoroughbreds, 4 Draft horses) and 228 breed-
matched controls. Using a haplotype-based approach based
on Illumina Equine SNP50 genotypes, the investigators
identified two protective loci in the Warmblood horses on
chromosomes 21 (P = 1.62 × 10-6) and 31 (P = 1.69 × 10−5)
associated with RLN. Neither of these chromosome regions
contained regions associated with neuropathies in other
mammals or candidate genes that could be immediately
linked to peripheral neuropathy. The present study reports
on use of a newer Illumina Equine SNP70 BeadChip to
conduct a GWAS on a large cohort of Thoroughbred
horses that were phenotypically characterized for RLN andheight. Specifically, we sought to identify risk loci associated
with RLN and in doing so, gain additional insight into the
etiopathogenesis of this disease. Because of the clinically re-
ported connection between height and RLN, we also exam-
ined their genetic association.
Methods
Horses
The protocol for phenotypic characterization and obtaining
blood samples and the informed consent forms were
approved by the Animal Use and Care Committee of
Michigan State University (MSU) and Cornell University.
Information on the risks and benefits of the investigation
was provided to the horse trainers/owners and informed
consent was signed before at the time the sample was
taken. Phenotypic data and venous blood samples (collected
in 10 ml EDTA tubes) were obtained from 573 Thorough-
bred horses evaluated by large-animal specialists from two
veterinary teaching hospitals (Michigan State University
and Cornell University) and by participating board-certified
veterinary surgeons at private practices throughout the US
(n = 10). A total of 505 horses at least 2 years old had re-
corded heights. In each unsedated horse, a videoendoscopic
examination of the larynx was performed and a laryngeal
grade of 1 to 4 [5] was assigned. This grade was derived
following observation of laryngeal movements during eup-
neic breathing, after induced-swallowing, and after nasal
occlusion maneuvers. Cases (RLN-affected), which were
largely obtained from participating veterinary surgeons,
were horses requiring corrective surgery for RLN. They had
laryngeal grades of 3 and 4 (n = 121 and n = 161, respect-
ively) and their median age was 3 years (range 1 to 21 years).
Controls, with a median age of 6 years (range 3-24) had la-
ryngeal scores of 1 (n = 268), were obtained from brood-
mare farms, private stables, veterinary hospital admissions,
and two racetracks. Sixteen putative controls received inter-
mediate laryngeal grades (1.5-2.5) and were excluded from
the RLN association analysis. With the exception of 3 three
year-old horses, all of the control horses were at least 4 years
old. All of the control horses were examined by either vet-
erinary teaching hospital faculty or participating veterinary
surgeons. Because, in 15% of horses, RLN may grade
change later in life [7], a few of the control animals may
have developed RLN at a later age, although excluding the
3 three-year old controls did not materially affect the re-
sults. Height at withers measurements was reported to the
nearest quarter hand (inch) and converted to centimeters.
Samples submitted by practitioners were shipped on dry
ice to the Pulmonary Laboratory, MSU and then stored
at −20°C. All samples were then processed by personnel in
the Cornell Veterinary Biobank [18]. DNA was extracted by
use of a DNA purification kit (Gentra Puregene or
Qiagen kit), and the concentration (spectrophotometric
absorbance at 260 nm) and quality (absorbance ratio:
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Two μg aliquots of DNA were allocated into 96-well
plates and stored at −20°C until samples were genotyped
at the Cornell University Biotechnology Resource Center.
Genotyping
The 573 Thoroughbred samples were genotyped using
Illumina Equine SNP70 arrays containing 65,157 markers.
Genotype calls were made in GenomeStudio using a
GenCall threshold of 0.25. Twenty samples with high miss-
ingness were re-run and an additional 29 samples passing
QC were run multiple times as technical replicates. A total
of 1,470 SNPs were excluded for high missingness (>10%)
and 7,751 monomorphic or rare SNPs (minor allele fre-
quency < 0.5%) were excluded. Duplicate concordance at
the remaining sites was >99.99%.
For the final dataset, only one array per sample was
retained, and an additional seven samples were excluded
because their imputed genotypic sex did not match the
phenotypic records, indicating a possible misidentification
of these samples. Two SNPs (BIEC2_403636 and BIEC2_
424368) were excluded because they showed evidence
of probe hybridization to multiple genomic locations, and
two other SNPs (BIEC2_346860 and BIEC2_840760) were
excluded due to low duplicate concordance rates. Addition-
ally, 197 markers were excluded for high heterozygosity
(P < 1 × 10−4 based on Hardy-Weinberg equilibrium) and
24 were excluded for low heterozygosity (P < 1 × 10−32); fil-
tering was more relaxed for low heterozygosity because
population structure would be expected to depress hetero-
zygosity somewhat from Hardy-Weinberg expectation. The
final unphased dataset contained 566 horses genotyped at
56,679 markers with a mean call rate of 99.77%. Principal
component analysis was computed using Eigenstrat [19]
and revealed no evidence of batch effects or significant
population stratification in the dataset (Additional file 1:
Figure S1). Phenotypic data for these 566 horses are
summarized in (see Additional file 2: Table S1).
Genome-wide association was performed using GEMMA
[20] after imputation of missing genotypes using ShapeIT
v2 [21]. In all cases, association analysis was performed by
means of a Wald test using the centered relatedness matrix
calculated by GEMMA. However, comparison of these as-
sociation results with standard association tests (no correc-
tion for population structure) revealed very little evidence
of P-value inflation due to population structure in our co-
hort (Additional file 3: Figure S2). We used a Bonferroni
significance cutoff of 1.16 × 10−6, conservatively estimating
43,055 independent comparisons (56,679 total markers less
13,624 markers that are in complete LD, r2 > 0.99, in our
study) and a family-wise error rate of α = 0.05.
To assess association to haplotypes in the ECA3 candi-
date region a set of SNPs centered on BIEC2_808543 and
encompassing approximately 2 Mb (ECA3:104737609–106517004) was selected. We further filtered this set to in-
clude only markers with a genotyping rate > 99% and a
MAF > 0.01, leaving 45 remaining markers. Linkage dis-
equilibrium between markers was examined using Haplo-
view v4.2 [22]. Haplotype associations to height and RLN
status were tested by a general linear model or chi-square
test using a sliding window of between 2 and 12 SNPs in
PLINK [23]. Regression modeling of the effect of height
and putative RLN loci was done with general linear models
using R with the package stats (v. 2.15.2) [24].Results
Association mapping of RLN
Using the full case–control dataset (550 horses: 282
cases and 268 controls) and correcting for sex and geld-
ing, the strongest association with RLN was centered on
a SNP, BIEC2_808543, adjacent to the ligand-dependent
nuclear receptor corepressor-like (LCORL) and non-
SMC condensing I complex, subunit G (NCAPG) genes
(P = 1.1 × 10−10, Figure 1A). Although this locus only
explains 6% of the variation in RLN in our cohort, we
estimated that our full dataset explained 0.45 ± 0.11 of
the variation in RLN score after accounting for sex and
gelding. This locus has previously been associated with
height in horses [25,26]. Including height as an add-
itional covariate in the model (489 horses: 274 cases
and 215 controls) yielded no significant associations
after correcting for population structure, although re-
gions of chromosomes 23 (36.2-39.8 Mb) and chromo-
some 18 (65.8-67.0 Mb showed suggestive associations
with RLN (P = 5.6 × 10−6 and 1.6 × 10−5, respectively,
Additional file 4: Figure S3A). GWAS for RLN without
covariates also yielded an additional suggestive associ-
ation on chrX at 57.8 Mb (Additional file 4: Figure
S3B). The effect of the LCORL/NCAPG and chromo-
some 18 QTLs was consistent between males and fe-
males whereas the chromosome 23 QTL appeared
stronger in females and the chromosome X QTL ap-
peared stronger in males (Table 1). GWAS for RLN in-
cluding BIEC2_808543 genotype as a covariate did not
reveal any additional associated regions (Additional
file 5: Figure S4A).Association mapping of body size
We performed GWAS on height using sex (mare, stal-
lion, and gelding) as a categorical covariate for the 505
horses of at least two years of age with recorded heights
(Figure 1B). The strongest association signal (P = 1.3 ×
10−22) centered on the same SNP, BIEC2_808543, in
LCORL/NCAPG locus that was the strongest association
for RLN. All 12 SNPs passing the Bonferroni signifi-
cance threshold were in this region (ECA3:104,403,770-
109,065,924). We estimated that the entire SNP70 panel
Figure 1 Manhattan plots of GWAS after accounting for population structure and sex and gelding (see Methods) for RLN and withers
height. A: RLN association in 282 Thoroughbred horse cases and 268 controls. B: Height association in 505 Thoroughbred horses.
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after accounting for sex and gelding [20].
Although height differed significantly between mares,
geldings, and stallions, sex and gelding only explained
6.9% of the variation in height in the samples. In
contrast the LCORL/NCAPG minor (G) allele count
at BIEC2_808543 had an effect of increasing height
3.7 cm (S.E. = 0.4) and explained 16.6% of the variation
in height in the dataset. This effect was roughly additive




All Freq aff 0.259
Freq unaff 0.119
P-value 4.0 × 10−9
Odds ratio 2.58
Males Freq aff 0.245
Freq unaff 0.103
P-value 4.3 × 10−6
Odds ratio 2.83
Females Freq aff 0.299
Freq unaff 0.135
P-value 5.4 × 10−5
Odds ratio 2.73model incorporating sex, gelding, and BIEC2_808543 ex-
plained 23.7% of the variance in height, and was not im-
proved by adding age to the model (−0.1 ± 0.06 cm/yr, P =
0.08). GWAS for height including BIEC2_808543 genotype
as a covariate did not reveal any additional associated
regions (Additional file 5: Figure S4B).
Correlated genetic signatures of RLN and height
A binomial regression model showed that height and














0.0011 4.0 × 10−5 0.042
0.495 3.81 1.54
Table 2 Frequency of LCORL/NCAPG marker BIEC2_808543
on withers height and RLN
N AA AG GG
Stallion 79 41 6
Gelding 157 68 6
Mare 137 64 8
Total 373 173 20
Mean height (cm)
Stallion 164.7 168.0 170.6
Gelding 162.4 166.7 168.5
Mare 160.7 164.5 169.8
Total 162.3 166.2 169.7
Risk of RLN
Stallion 0.924 1 1
Gelding 0.313 0.621 0.833
Mare 0.263 0.453 0.875
Total 0.428 0.647 0.900
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the variables were correlated, they were both significant
in the full model for RLN, jointly incorporating the
effects of sex, gelding, height, and the putative RLN loci
on ECA 3, 18, 23 and X (Table 3).
Because of the similar GWAS results for height and
RLN, we used bivariate restricted maximum likelihood
(REML) analysis [27] to estimate the genetic correlation
between height and quantitative RLN score. Bivariate
REML estimates of “chip heritability” after accounting
for sex and gelding were remarkably similar to our
LMM estimates (0.22 and 0.46 for height and RLN, re-
spectively), and the estimated genomic correlation be-
tween height and RLN was nearly complete (0.98 ± 0.19).
Chromosomes 3 and X explained the largest proportion
of the variance in height and were also significantly asso-
ciated with RLN severity, although other chromosomes
also show elevated associations with RLN (e.g., ECA6
and ECA9, see Additional file 6: Figure S5).
Haplotype analysis revealed that height is associated
with an eight SNP block spanning ECA3: 105363241–
105830625 (uncorrected P = 8.18 × 10−23). This genomicTable 3 Effect sizes of height and QTLs on RLN using binomia
AIC Height
Sex + gelding 619.1
Sex + gelding + height 505.8 1.68
Sex + gelding + LCORL/NCAPG 580.3
Sex + gelding + height + LCORL/NCAPG 499.1 1.42
Sex + gelding + height + 4 loci 444.8 1.61
P-value (full model) 1.3 × 10−8
P-values are given for the full model incorporating sex, gelding, height, and geneticregion includes both the LCORL and NCPG genes
(Figure 2). The haplotype generating the smallest p-value
for RLN is a seven SNP block overlapping with the height
block by two markers (uncorrected P = 6.29 × 10−11) (see
Additional file 7: Table S2 and Additional file 8: Table S3).
This block spans ECA3: 105829484–105884170 and in-
cludes the 5’ half of the FAM184B gene (Figure 2). Examin-
ation of the 1132 chromosomes phased using ShapeIT
revealed that 209 chromosomes bear both the RLN and
height-associated haplotype blocks. Only one chromosome
possessed the height block but not the RLN haplotype. 81
chromosomes contained the RLN haplotype but not the
height associated block, leaving 841 chromosomes posses-
sing only other haplotypes.
Discussion
The selective breeding of domestic animals for desirable
traits has often been accompanied by the appearance of
genetically determined undesirable characteristics: exam-
ples include malignant hyperthermia in swine selected
for rapid increase in muscle mass, osteoporosis in chick-
ens selected for high rates of egg production, and hyper-
kalemic periodic paralysis in Quarterhorses selected for
muscular appearance. In general, horses have been se-
lectively bred for power and speed. The former requires
size and muscle mass while the latter requires height
(long legs), a compact muscle mass close to the trunk,
and high rates of maximal oxygen consumption. Al-
though selection for height apparently has been accom-
panied by an increased prevalence of RLN, the genetic
basis for this is currently unknown.
The current study, which used the largest cohort of RLN-
affected and unaffected horses ever assembled from a single
breed revealed a very strong genetic correlation between
RLN and height. This association was previously well
known across breeds (ponies are rarely clinically affected by
RLN and draft horses frequently are), but has never been
demonstrated over the small range of heights (152 to
178 cm) spanned in the present study. This was evident not
only in the clinical observations (cases were taller than con-
trols), but also in the GWAS results. The haplotype associa-
tions for height and RLN were coincident and the genetic
correlation between the traits was >90%.l regression
LCORL/NCAPG chr18_QTL chr23_QTL chrX_QTL
1.17
0.63
0.64 −0.85 0.60 1.46
0.0067 5.2 × 10−6 1.3 × 10−5 3.6 × 10−5
effects.
Figure 2 Single marker association tests (A.) followed by haplotype analysis (C.) reveals different, but overlapping blocks correlated
with RLN (orange) and height (black). Candidate genes LCORL and NCAPG are encompassed by the height haplotype, while a portion of the
FAM184B gene lies within the RLN associated haplotype (B). Adapted from the UCSC Genome Browser.
Boyko et al. BMC Genomics 2014, 15:259 Page 6 of 9
http://www.biomedcentral.com/1471-2164/15/259The phenotype of RLN was defined based on the pres-
ence (cases) or absence (controls) of endoscopically vis-
ible failure of abduction of the left arytenoid and
associated vocal fold. This clinical and functional defin-
ition was used because veterinarians in the field use it
and because it has important implications for athletic
performance. There were two reasons for selection of
grade 3 as the threshold score for a case: first, horses
with this grade are unable to maintain vocal fold abduc-
tion and therefore require surgical correction to restore
their performance; and second, failure of abduction is
easily recognized endoscopically by experienced veteri-
narians (those participating in selection of cases examine
many racehorses before sale as well as clinical cases).
However, histopathological examination of the intrinsicmuscles of the larynx can reveal muscle fiber-type
regrouping (7evidence of axon death and reinnervation
from a neighboring axon) in some horses that do not
have clinical evidence of laryngeal paresis [28] and there-
fore would be controls under the definition used in the
present investigation. Furthermore, foals can demon-
strate fiber-type regrouping at birth [29] and ponies have
fiber-type regrouping but rarely develop the clinical syn-
drome. Definition of cases and controls based on the
presence or absence of fiber-type regrouping is not cur-
rently practical, and it is possible that clinical expression
of RLN involves factors other than just changes in
muscle fiber type.
Recently, several independent studies have documented
strong associations between the LCORL/NCAPG region
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tive mutation has been detected to date. A role for both
LCORL and NCAPG in growth is supported by well-
validated associations to human height [32,33], and to fetal
growth rate in cattle [34].
Within the Thoroughbred breed, the ECA3 locus ap-
pears to have the single largest effect on withers height
(Figure 1B). Previous work in 16 diverse breeds selected
for extreme body size identified three significant loci in
addition to ECA3 (HMGA2, ZFAT, and LASP1) as well
as a Thoroughbred-specific QTL on ECA28, but no sig-
nal for these loci was detected in this dataset [26]. Al-
though marker coverage for HMGA2 is poor on the
Illumina SNP70 product, the same markers for ZFAT are
included in this analysis and segregate at ~ 20% in our
cohort, but do not appear to impact withers height. The
association of ZFAT with height is replicated in a study
of 1,077 Franches-Montagnes horses [25], suggesting the
effect of the size QTL near ZFAT may be dependent on
genetic background. The previous estimate that 59% of
the variation in height in Thoroughbreds was explained
by LCORL/NCAPG and the QTL on ECA28 is signifi-
cantly higher than our estimate of 24% based on the
entire SNP dataset. This may reflect an overestimation
in their analysis due to small sample size (N = 48) or
an underestimation in ours due to the small range of
Thoroughbred heights, environmental variability, and/
or measurement error.
Our study confirms anecdotal evidence and previous
reports in draft breeds identifying an association be-
tween RLN and large size in horses [11,12]. However,
the nature of this association remains unknown. Cer-
tainly, large body size will increase the overall length of
the recurrent laryngeal nerve, perhaps increasing the
risk for mechanical injury of the nerve during athletic
performance or for damage associated with defects in
axonal transport. Alternatively, LCORL and NCAPG are
genes encoding transcription factors and could have di-
verse targets with varying physiological functions. Thus,
the same causative mutation may be implicated for both
body size and RLN phenotypes. Lastly, given extensive
LD across the ECA3 locus, RLN and body size may be
influenced by two independent genetic changes associ-
ated by linkage. Further work will be needed to distin-
guish which of these three hypotheses is the most likely
explanation for the association between this ECA3 locus
and RLN.
Besides the LCORL/NCAPG locus, the chromosome
18 and X candidate loci are near to genes that are likely
to affect muscle physiology and growth in horses (MSTN
and ITM2A). Interestingly, the primary association signal
in [17] is also located in a myosin gene (MYO9B), a can-
didate gene that may be very relevant to the pathology
of a distal axonopathy like RLN. Yet, our study suggeststhat QTLs on chromosome 21 and 31 identified by
Dupuis et al. [17] are not an important influence on
RLN in our Thoroughbred cohort. Genetic background
may play an important role in a polygenic and multifac-
torial condition like RLN. Environmental conditions are
also drastically different in the actively training racehorse
(the majority of animals sampled for this work) and
Warmblood horses used primarily for the sports of show
jumping and dressage. Mean age of animals between
these two studies was also quite different. Cases used
here were on average just 3 years of age versus ~8 years
of age in the Dupuis study ([17]; Dupuis personal com-
munication). Therefore, the ECA3 locus may be most
important for development of RLN in young horses in
training for near maximal athletic performance.Conclusions
The results of this study add further confirmation to the
association between height and the clinical occurrence
of RLN and indicate the close relationship between the
genetic loci determining these two characteristics. However,
despite being statistically significant, LCORL/NCAPG
accounted for only 6% of the variation in RLN. However,
in these Thoroughbreds, the proportion of variation of
RLN explained by the entire SNP70 set (“chip heritability”)
was 45%, which, although much higher than in most com-
plex diseases [35], suggests that multimarker tests will be
needed for accurate prediction of RLN risk. Because of the
nearly complete genetic correlation between height and
RLN risk in Thoroughbreds, it may be difficult reduce RLN
prevalence without altering body size or other growth char-
acteristics that may be important for racing performance.
However, our results do not preclude the possibility of
modifier loci that attenuate RLN risk without reducing size
or performance, or that the RLN risk allele is distinct but
tightly linked to the body size locus on ECA3.Additional files
Additional file 1: Figure S1. Principal component analysis (PCA) of
genotype data shows no stratification according to RLN status or
evidence for significant population substructure within the cohort.
Red = RLN affected, black = control.
Additional file 2: Table S1. Summary of horses used for height and
RLN association mapping.
Additional file 3: Figure S2. QQ-plot for RLN (A) and height (B). There
is little genomic inflation of P-values in the data in uncorrected PLINK
(gray) or population structure corrected GEMMA (black) association scans
for height (B) in our dataset. The top dozen SNPs are all linked to the
ECA3 locus near LCORL/NCAPG. The RLN association (A) is shown with sex
as the covariate in GEMMA (Figure 1B). Genomic inflation (γ) is 1.0058.
Additional file 4: Figure S3. A: GWAS of RLN using sex, gelding, and
height as covariates yields additional suggestive associations on ECA18
and ECA23 (489 horses: 274 cases and 215 controls). B: GWAS of RLN
without covariates yields an additional signal on chromosome X.
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http://www.biomedcentral.com/1471-2164/15/259Additional file 5: Figure S4. Genome-wide association of RLN (A) and
height (B) using sex, gelding, and BIEC2_808543 (LCORL/NCAPG) allele
count as covariates shows no other significant genetic associations with
these traits.
Additional file 6: Figure S5. Partitioning the variance explained by
each chromosome for height (x-axis) and RLN grade (y-axis) in our
sample (550 horses) after accounting for sex and gelding as covariates.
The variance explained for RLN case/control was not estimable by the
REML method with sex and gelding covariates; therefore, RLN grade (1-4)
was used instead. REML estimated total variance explained genome-wide
for height and RLN grade is 59% and 61%, respectively, somewhat higher
than the estimates obtained by the LMM method or by bivariate REML
(see Methods).
Additional file 7: Table S2. P-values resulting from a haplotype
association test for withers height.
Additional file 8: Table S3. P-values resulting from a haplotype
association test for RLN status (case/control).Competing interests
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